Long-term study of the association of adipokines and glucose variability with diabetic complications

키워드

참고문헌 (38)

1. Pradhan AD, "C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus", JAMA, 286, pp.327~334 (2001)[DOI]
2. Devaraj S, "Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes", Diabetes, 55, pp.774~779 (2006)[DOI]
3. Lafontan M, "Adipose tissue and adipocyte dysregulation", Diabetes Metab, 40, pp.16~28 (2014)[DOI]
4. Romacho T, "Adipose tissue and its role in organ crosstalk", Acta Physiol (Oxf ), 210, pp.733~753 (2014)[DOI]
5. Mills KT, "Circulating adipocytokines and chronic kidney disease", PLoS One, 8, pp.e76902~ (2013)[DOI]
6. Adamczak M, "Adiponectin in patients with chronic kidney disease", Semin Dial, 22, pp.391~395 (2009)[DOI]
7. Briffa JF, "Adipokines as a link between obesity and chronic kidney disease", Am J Physiol Renal Physiol, 305, pp.F1629~F1636 (2013)[DOI]
8. 민혜숙, "Effects of Toll-like receptor antagonist 4,5-dihydro-3-phenyl-5-isoxasole acetic acid on the progression of kidney disease in mice on a high-fat diet", Kidney Research and Clinical Practice, 33(1), pp.33~44 (2014), 대한신장학회
9. Deng Y, "Adipokines as novel biomarkers and regulators of the metabolic syndrome", Ann N Y Acad Sci, 1212, pp.E1~E19 (2010)
10. Jin JooCha, "Plasma leptinconcentrationsaregreaterintypeIIdiabeticpatientsand stimulatemonocytechemotacticpeptide-1synthesisviathemitogen-activatedproteinkinase", extracellularsignal-regulatedkinasepathway, 2012, pp.31(3), 177~185[DOI]
11. Alberti KG, "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation", Diabet Med, 15, pp.539~553 (1998)[DOI]
12. Chamberlain JJ, "Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association standards of medical care in diabetes", Ann Intern Med, 164, pp.542~552 (2016)[DOI]
13. Tuttle KR, "Diabetic kidney disease: a report from an ADA Consensus Conference", Am J Kidney Dis, 64, pp.510~533 (2014)[DOI]
14. Guo X, "Adiponectin retards the progression of diabetic nephropathy in db", db mice by counteracting angiotensin II, 2014, pp.2, e00230~
15. Jorsal A, "Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy", Kidney Int, 74, pp.649~654 (2008)[DOI]
16. Menon V, "Adiponectin and mortality in patients with chronic kidney disease", J Am Soc Nephrol, 17, pp.2599~2606 (2006)[DOI]
17. Looker HC, "Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes", J Clin Endocrinol Metab, 89, pp.4010~4017 (2004)[DOI]
18. Martinez Cantarin MP, "Adiponectin receptor and adiponectin signaling in human tissue among patients with end-stage renal disease", Nephrol Dial Transplant, 29, pp.2268~2277 (2014)[DOI]
19. Guebre-Egziabher F, "Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function", Nephrol Dial Transplant, 20, pp.129~134 (2005)[DOI]
20. Martinez Cantarin MP, "The adipose tissue production of adiponectin is increased in end-stage renal disease", Kidney Int, 83, pp.487~494 (2013)[DOI]
21. Herder C, "Differential association between biomarkers of subclinical inflammation and painful polyneuropathy: results from the KORA F4 study", Diabetes Care, 38, pp.91~96 (2015)[DOI]
22. Ussar S, "Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine", Diabetes, 61, pp.2289~2298 (2012)[DOI]
23. Yoo HJ, "Association of glypican- 4 with body fat distribution, insulin resistance, and nonalcoholic fatty liver disease", J Clin Endocrinol Metab, 98, pp.2897~2901 (2013)[DOI]
24. Watanabe K, "K-glypican: a novel GPI-anchored heparin sulfate proteoglycan that is highly expressed in developing brain and kidney", J Cell Biol, 130, pp.1207~1218 (1995)[DOI]
25. Strate I, "Glypican4 promotes cardiac specification and differentiation by attenuating canonical Wnt and Bmp signaling", Development, 142, pp.1767~1776 (2015)[DOI]
26. Chang GY, "Tracing the footsteps of glomerular insulin signaling in diabetic kidney disease", Kidney Int, 79, pp.802~804 (2011)[DOI]
27. Hirakawa Y, "Impact of visit- to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial", Diabetes Care, 37, pp.2359~2365 (2014)[DOI]
28. Muggeo M, "Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study", Diabetes Care, 23, pp.45~50 (2000)[DOI]
29. Ceriello A, "Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients", Diabetes, 57, pp.1349~1354 (2008)[DOI]
30. Wu J, "Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human", Cell, 150, pp.366~376 (2012)[DOI]
31. Roca-Rivada A, "FNDC5", irisin is not only a myokine but also an adipokine, 2013, pp.8, e60563~
32. Liu JJ, "Lower circulating irisin is associated with type 2 diabetes mellitus", J Diabetes Complications, 27, pp.365~369 (2013)[DOI]
33. Liu JJ, "Relationship between circulating irisin, renal function and body composition in type 2 diabetes", J Diabetes Complications, 28, pp.208~213 (2014)[DOI]
34. Li DJ, "Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation", Acta Physiol (Oxf ), 213, pp.711~721 (2015)[DOI]
35. Moschen AR, "Visfatin, an adipocytokine with proinflammatory and immunomodulating properties", J Immunol, 178, pp.1748~1758 (2007)[DOI]
36. 강영선, "The Role of Visfatin in Diabetic Nephropathy", 전남의대학술지, 47(3), pp.139~143 (2011), 의과학연구소
37. Vikram NK, "Anthropometry and body composition in northern Asian Indian patients with type 2 diabetes: receiver operating characteristics (ROC) curve analysis of body mass index with percentage body fat as standard", Diabetes Nutr Metab, 16, pp.32~40 (2003)
38. Kollerits B, "Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study", Kidney Int, 71, pp.1279~1286 (2007)[DOI]

관련 논문AI추천